Aethlon Medical

AEMD

Market cap $1.74M

AEMD Hedge Fund Activity: Q1 2026 in Review

12 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2026, worth a combined $155K — up 240% from $45.6K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AEMD positions and 2 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $55.4K. The largest seller was Citigroup, exiting entirely with an estimated $91 sold.

• 12 institutional investors held Aethlon Medical (AEMD) as of Q1 2026, up from 8 in Q4 2025.
• Funds reported $155K of Aethlon Medical stock for Q1 2026, up 240% quarter-over-quarter.
• 6 funds opened new Aethlon Medical positions in Q1 2026 and 2 closed out, a net change of +4 holders.
• The largest Aethlon Medical buyer in Q1 2026 was Geode Capital Management, an estimated $55.4K added.
• The largest Aethlon Medical seller in Q1 2026 was Citigroup, an estimated $91 sold.

Based on aggregated 13F filings for Q1 2026.